Want to see ATLN full AI Analyst Report?
ATLN Stock Chart & Stats
$4.45
$0.18(3.08%)
At close: 4:00 PM EST
$4.45
$0.18(3.08%)
Day’s Range― - ―
52-Week Range$0.41 - $5.25
Previous Close$6.28
Volume7.10K
Average Volume (3M)364.23K
Market Cap
$67.28M
Enterprise Value$132.09M
Total Cash (Recent Filing)$24.10M
Total Debt (Recent Filing)$312.46M
Price to Earnings (P/E)―
Beta-0.81
Next Earnings
Aug 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.32
Shares Outstanding81,293,030
10 Day Avg. Volume70,257
30 Day Avg. Volume364,234
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-2.27
Price to Sales (P/S)0.17
P/FCF Ratio-16.34
Enterprise Value/Market Cap1.96
Enterprise Value/Revenue0.23
Enterprise Value/Gross Profit2.35
Enterprise Value/Ebitda-2.27
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.61
Revenue Forecast (FY)$481.08M
Bulls Say, Bears Say
Bulls Say
Scale From Circle8 AcquisitionThe acquisition enlarged recurring revenue scale to >$1.1–$1.2B annualized, giving the company enterprise-level scale to pursue large bids, diversify customer mix across regions and service lines, and capture operating leverage as integrations drive margin recovery over time.
Large Public-sector ContractsA multi-year renewal with Rijkswaterstaat and other Dutch public-sector framework wins create a durable backlog and validate mission-critical delivery. Public-sector frameworks tend to be sticky and provide predictable revenue streams that support medium-term cash visibility and pipeline conversion.
Strategic Rebrand And Leadership AlignmentManagement reshuffle places an experienced platform and M&A operator at the helm, aligning governance with a combined technology and workforce services strategy. This increases odds of disciplined integration, M&A execution and commercialization of scale to improve longer-term operating performance.
Bears Say
High Leverage Vs EquityElevated debt relative to a thin and historically volatile equity base limits financial flexibility, raises refinancing and covenant risk, and increases interest burden. This structural capital tension constrains investment, magnifies downturn sensitivity, and pressures strategic options.
Negative Cash GenerationSustained negative operating and free cash flow implies ongoing cash burn and reliance on external financing or asset sales. That erodes resilience, restricts the company's ability to fund integration, invest in growth areas like AI/cybersecurity, and raises the likelihood of dilutive capital raises.
Low Margins And Ongoing LossesDespite revenue rebound, low gross margins and persistent operating losses indicate limited current pricing power or cost inefficiencies. Structural margin improvement will be required to absorb fixed costs and service debt; without it, profitability remains fragile and dependent on execution.
Atlantic International News
ATLN FAQ
What was Atlantic International’s price range in the past 12 months?
Atlantic International lowest stock price was $0.41 and its highest was $5.25 in the past 12 months.
What is Atlantic International’s market cap?
Atlantic International’s market cap is $67.28M.
When is Atlantic International’s upcoming earnings report date?
Atlantic International’s upcoming earnings report date is Aug 13, 2026 which is in 39 days.
How were Atlantic International’s earnings last quarter?
Currently, no data Available
Is Atlantic International overvalued?
According to Wall Street analysts Atlantic International’s price is currently Overvalued.
Does Atlantic International pay dividends?
Atlantic International does not currently pay dividends.
What is Atlantic International’s EPS estimate?
Atlantic International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Atlantic International have?
Atlantic International has 81,293,030 shares outstanding.
What happened to Atlantic International’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Atlantic International?
Currently, no hedge funds are holding shares in ATLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Atlantic International Stock Smart Score
Company Description
Atlantic International
Based in Billerica, Massachusetts, and established in 2013, Atlantic International Corp. (which operated as SeqLL Inc. until its name change in June 2024) underwent a significant corporate change on June 18, 2024, when it was acquired by Lyneer Investments, LLC, via a reverse merger. The company operates within the life sciences sector, providing specialized instrumentation and research services. Its primary focus is on generating innovative scientific assets and proprietary intellectual property across various "omics" disciplines. Central to its offerings is the True Single Molecule Sequencing (tSMS) platform. This advanced technology provides a unique single-molecule approach to DNA and RNA sequencing by directly detecting nucleic acids. It empowers researchers to analyze billions of individual molecules within a single experiment, ensuring the generation of highly accurate and reproducible data. Atlantic International's sophisticated solutions cater to diverse applications, including biomarker discovery and the development of diagnostic assays. Its clientele spans academic institutions (such as universities), governmental research centers, and leading companies in the biotechnology and pharmaceutical industries. The company also fosters key collaborations, including an R&D agreement with the U.S. Department of Justice's Federal Bureau of Investigation to assess the forensic potential of direct RNA sequencing using its tSMS platform, and a partnership with the Weizmann Institute of Science to advance and implement cutting-edge single-molecule technologies.
Technical Analysis
Ownership Overview
24.37% Insiders
1.00% Mutual Funds
0.03% Other Institutional Investors
73.52% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---